A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/07/2002	US20020165248 Opiod analgesic
11/07/2002	US20020165247 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/07/2002	US20020165246 Administration of sleep restorative agents
11/07/2002	US20020165244 Mucin synthesis inhibitors
11/07/2002	US20020165243 JAK-3 inhibitors for treating allergic disorders
11/07/2002	US20020165242 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
11/07/2002	US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002	US20020165240 Method of treating proliferative diseases using Eg5 inhibitors
11/07/2002	US20020165239 Conjugates of sodium channel blockers and methods of using the same
11/07/2002	US20020165238 Such as 1-(3-carboxypyridyl-2)-4-methyl-2- phenylpiperazine dihydrate; antidepressants
11/07/2002	US20020165237 Treatment of the insulin resistance syndrome
11/07/2002	US20020165235 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
11/07/2002	US20020165234 Selective B3 adrenergic agonists
11/07/2002	US20020165233 Quinoxaline containing medicaments for post exposure prophylaxis of an HIV infection
11/07/2002	US20020165229 Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases
11/07/2002	US20020165226 Estrogen receptor modulators
11/07/2002	US20020165225 Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
11/07/2002	US20020165224 Use of y-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
11/07/2002	US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/07/2002	US20020165221 Cellular antigrowth agents
11/07/2002	US20020165220 Topical dispersion; water solutions; evaporation
11/07/2002	US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/07/2002	US20020165217 Combination treatment for anxiety and depression
11/07/2002	US20020165216 Controlling oxidation stresses
11/07/2002	US20020165214 Cosmetic or dermatological use of 7-hydroxylated steroids
11/07/2002	US20020165213 Estrogen induced neural stem cell increase
11/07/2002	US20020165212 Antiproliferative agent; wound healing agents; antiinflammatory agents
11/07/2002	US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler
11/07/2002	US20020165209 Low dose estrogen interrupted hormone replacement therapy
11/07/2002	US20020165207 Mixture of nerve growth factor, aldose reductase inhibitor and oxidation resistance
11/07/2002	US20020165206 Inhibitory or blocking agents of molecular generating and/or inducing functions
11/07/2002	US20020165204 Anticarcinogenic agents
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165202 Antiinflammatory agents; antiproliferative agents
11/07/2002	US20020165201 Cyanoguanidine prodrugs
11/07/2002	US20020165200 Central nervous system disorders
11/07/2002	US20020165197 Administering adenosine receptor ligand
11/07/2002	US20020165189 Oligoribonucleotides and ribonucleases for cleaving RNA
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165179 Multifunctional nanodevice platform
11/07/2002	US20020165178 Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
11/07/2002	US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription
11/07/2002	US20020165172 Compositions and methods for treating intracellular diseases
11/07/2002	US20020165170 Antagonists that bind CD1d and inhibit activation of CD1d-restricted natural killer (NK) T cells, agents that block CD1d-specific receptors and CD1d decoys and a carrier or diluent; contact dermatitis for example
11/07/2002	US20020165169 Therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
11/07/2002	US20020165168 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/07/2002	US20020165166 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor
11/07/2002	US20020165164 New effectors of dipeptidyl peptidase IV for topical use
11/07/2002	US20020165160 Fibroblast growth factor (FGF) mutein; treating coronary artery disease (atherosclerosis)
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165131 Histidine-rich glycoprotein
11/07/2002	US20020165122 Method and compositions for the treatment or amelioration of female sexual dysfunction
11/07/2002	US20020165121 Topical application for treating toenail fungus
11/07/2002	US20020165120 Mixture of eletriptan and glycoprotein inhibitor; headache therapy
11/07/2002	US20020165119 Method of treating inflammatory conditions by inhibiting cytosolic phospholipase A2
11/07/2002	US20020165117 Use of purinergic receptor modulators and related reagents
11/07/2002	US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002	US20020164773 Generation of extracellular, polysaccharides of basidiomycetes mushrooms; obtain fungi, propagate in nutrient broths, isolating biomass from culture by precipitation
11/07/2002	US20020164767 DNA encoding the human serine protease C-E
11/07/2002	US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/07/2002	US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002	US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002	US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002	US20020164579 Prevention of cell migration initiation with CMV US28 receptor antagonists
11/07/2002	US20020164389 Method for topical treatment of carpal tunnel syndrome
11/07/2002	US20020164388 Composition and method for reducing the risk or progression of cardiovascular, glaucoma and tardive dyskinesia diseases
11/07/2002	US20020164386 Topical applying glucosamine containing cream
11/07/2002	US20020164385 Administering human papillomavirus protein antagonist
11/07/2002	US20020164383 Composition and method for augmenting or restoring the production of fetal protein in patient in need thereof
11/07/2002	US20020164381 Mixture containing sulfur and sulfur compound
11/07/2002	US20020164379 Oxygen-containing ophthalmic composition
11/07/2002	US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/07/2002	US20020164376 Microparticles and their use in cancer treatment
11/07/2002	US20020164373 Opioid sustained-released formulation
11/07/2002	US20020164369 Novel soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
11/07/2002	US20020164368 Oral administering; mixture containing cationic salt
11/07/2002	US20020164367 Mixture of oleanolic acid and polysaccharides
11/07/2002	US20020164352 Dietetics; anticholesterol agents; antidiabetic agents
11/07/2002	US20020164347 Neoglycoproteins
11/07/2002	US20020164329 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides
11/07/2002	US20020164319 Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
11/07/2002	US20020164317 Cancer immune composition for prevention and treatment of individuals
11/07/2002	US20020164314 Therapy for nervous system disorders
11/07/2002	US20020164306 Concurrent administering with protein replacement therapy
11/07/2002	US20020164287 Azo compounds for type i phototherapy
11/07/2002	DE10204637A1 Pharmaceutical, nutritional or food additive composition containing gamma-linolenic acid, isoflavone and lignan, is effective e.g. against tumors, osteoporosis and premenstrual syndrome
11/07/2002	DE10121375A1 Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut Use of isoflavonoids in cosmetic or dermatological preparations for the prophylaxis against and treatment of sensitive skin
11/07/2002	DE10121252A1 Behandlung der Akne Treatment of acne
11/07/2002	DE10121102A1 Triazolopyrimidine Triazolopyrimidines
11/07/2002	DE10120834A1 Neue Schmerzmittel, die Inhibitoren von TRP-Kanälen sind New painkillers that are inhibitors of TRP channels are
11/07/2002	DE10119863A1 Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen Use of deoxypeganine for the treatment of psychiatric or cerebral symptoms
11/07/2002	DE10119862A1 Verwendung von Galanthamin zur Behandlung von Krankheitserscheinungen des zentralen Nervensystems aufgrund von Intoxikationen mit psychotropen Substanzen Use of galantamine for the treatment of symptoms of disease of the central nervous system due to intoxication with psychotropic substances
11/07/2002	DE10118776A1 Medicinal use of vinegar for killing bacteria, mold fungi, yeasts and acid-labile viruses, e.g. by skin treatment, inhalation, gargling or intestinal cleaning
11/07/2002	DE10109897A1 Fakultativ kationische Liposomen und Verwendung dieser Optional cationic liposomes and use of these
11/07/2002	CA2744115A1 Carbonic anhydrase activators for enhancing learning and memory
11/07/2002	CA2672001A1 N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same
11/07/2002	CA2665516A1 Drug efflux pump inhibitor

1 ... 5657 5658 5659 5660 5661 5662 5663 5664 5665 5666 5667 5668 5669 5670 5671 5672 5673 5674 5675 5676 5677 ... 7860